Specify Company / Ticker to Get the Summary
Dividend History MNMD
Dividend Analytics MNMD
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Mind Medicine Inc
MNMDMind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York. Address: One World Trade Center, New York, NY, United States, 10007
Analytics
WallStreet Target Price
24.50 USDP/E Ratio
–Dividend Yield
–Financials MNMD
Results | 2019 | Dynamics |